These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 20433799)

  • 1. Bloody diarrhea and gastrointestinal tract wall thickening after hematopoietic stem cell transplantation and donor lymphocytes infusion.
    Lin HF; Chao TY; Lee HS
    Gastroenterology; 2010 Jun; 138(7):e5-6. PubMed ID: 20433799
    [No Abstract]   [Full Text] [Related]  

  • 2. Simultaneous occurrence of Clostridium difficile and Cytomegalovirus colitis in a recipient of autologous stem cell transplantation.
    Kottaridis PD; Peggs K; Devereux S; Goldstone AH; Mackinnon S
    Haematologica; 2000 Oct; 85(10):1116-7. PubMed ID: 11025618
    [No Abstract]   [Full Text] [Related]  

  • 3. [Second transplant from the same donor without conditioning for bone marrow aplasia after non-myeloablative hematopoietic stem cell transplantation for chronic myeloid leukemia].
    Ishikawa I; Miyamura K; Yamada M; Sasaki O; Harigae H; Kameoka J; Meguro K; Sasaki T
    Rinsho Ketsueki; 2005 Dec; 46(12):1288-92. PubMed ID: 16447801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for late cytomegalovirus infection after allogeneic stem cell transplantation using HLA-matched sibling donor: donor lymphocyte infusion and previous history of early CMV infection.
    Kim DH; Kim JG; Lee NY; Sung WJ; Sohn SK; Suh JS; Lee KS; Lee KB
    Bone Marrow Transplant; 2004 Jul; 34(1):21-7. PubMed ID: 15133483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of BCR-ABL positive acute lymphoblastic leukemia in donor cells after allogeneic hematopoietic cell transplantation for Philadelphia-positive acute lymphoblastic leukemia.
    Athanasiadou A; Stamatopoulos K; Sakellari I; Zorbas I; Gaitatzi M; Fassas A; Anagnostopoulos A
    Bone Marrow Transplant; 2004 Jul; 34(2):189-91. PubMed ID: 15156167
    [No Abstract]   [Full Text] [Related]  

  • 6. Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.
    Slavin S; Naparstek E; Nagler A; Ackerstein A; Kapelushnik J; Or R
    Exp Hematol; 1995 Dec; 23(14):1553-62. PubMed ID: 8542946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of leukemia relapse after allogeneic hematopoietic stem cell transplantation by donor lymphocyte infusion and STI-571.
    Baron F; Frère P; Fillet G; Beguin Y
    Haematologica; 2001 Sep; 86(9):993-4. PubMed ID: 11532632
    [No Abstract]   [Full Text] [Related]  

  • 8. Ex vivo expansion and prophylactic infusion of CMV-pp65 peptide-specific cytotoxic T-lymphocytes following allogeneic hematopoietic stem cell transplantation.
    Micklethwaite K; Hansen A; Foster A; Snape E; Antonenas V; Sartor M; Shaw P; Bradstock K; Gottlieb D
    Biol Blood Marrow Transplant; 2007 Jun; 13(6):707-14. PubMed ID: 17531781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of monitoring minimal residual disease in the patients with donor lymphocyte infusion as intervention of relapsed/refractory acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation.
    Ma X; Wu D; Sun A; Qiu H; Fu Z; Wu X; Chen S; Mohty M
    Am J Hematol; 2010 Feb; 85(2):141-2. PubMed ID: 20029991
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of poor marrow graft function with allogeneic CD34+ cells immunoselected from G-CSF-mobilized peripheral blood progenitor cells of the marrow donor.
    Arseniev L; Tischler HJ; Battmer K; Südmeier I; Casper J; Link H
    Bone Marrow Transplant; 1994 Nov; 14(5):791-7. PubMed ID: 7534162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevention and treatment of cytomegalovirus infection in haematopoietic stem cell transplantation.
    Tuthill M; Chen F; Paston S; De La Peña H; Rusakiewicz S; Madrigal A
    Cancer Immunol Immunother; 2009 Sep; 58(9):1481-8. PubMed ID: 19466407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-emptive immunotherapy with CD8-depleted donor lymphocytes after CD34-selected allogeneic peripheral blood stem cell transplantation.
    Baron F; Siquet J; Schaaf-Lafontaine N; Baudoux E; Hermanne JP; Fillet G; Beguin Y
    Haematologica; 2002 Jan; 87(1):78-88. PubMed ID: 11801468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term persistent lymphopenia in hematopoietic stem cell donors after donation for donor lymphocyte infusion.
    Nicolini FE; Wattel E; Michallet AS; Bourgeot JP; Tremisi JP; Hequet O; Michallet M
    Exp Hematol; 2004 Nov; 32(11):1033-9. PubMed ID: 15539080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Education and Imaging. Gastrointestinal: cytomegalovirus enterocolitis.
    Karagiannis S; Kosmadakis G; Goulas S; Boletis J; Mavrogiannis C
    J Gastroenterol Hepatol; 2007 Apr; 22(4):594. PubMed ID: 17376058
    [No Abstract]   [Full Text] [Related]  

  • 15. [Recommendations for the diagnosis and therapy of cytomegalovirus infection after stem-cell transplantation. The Research Alliance on the Complications of Organ Transplantation due to Herpes Viruses].
    Einsele H; Herbart H; Bock T; Müller C; Fleckenstein B; Mach M; Stamminger T; Jahn G; Sinzger C; Koszinowski U; Meyer-König U; Mertens T; Plachter B; Reddehase MJ; Schmidt CA
    Dtsch Med Wochenschr; 1999 Apr; 124(16):501-6. PubMed ID: 10341755
    [No Abstract]   [Full Text] [Related]  

  • 16. Unusual cytomegalovirus complications after autologous stem cell transplantation for large B cell lymphoma: massive gastrointestinal hemorrhage followed by a communicating hydrocephalus.
    Cohen Y; Paltiel O; Amir G; Da'as N; Engelhard D; Polliack A
    Bone Marrow Transplant; 2002 Apr; 29(8):715-6. PubMed ID: 12180120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical study of allogeneic hematopoietic stem cell transplantation for relapsed/refractory acute lymphocytic leukemia].
    Ma X; Wu DP; Sun AN; Fu ZZ; Tang XW; Wu XJ; Liu YJ; Qiu HY; Miao M; Han Y; Jin ZM; Zhao Y; Xue SL; Wang Y; Chen SN; He GS; Zhou HX; Chang HR
    Zhonghua Xue Ye Xue Za Zhi; 2009 Feb; 30(2):73-6. PubMed ID: 19563014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late onset membranous nephropathy complicating donor lymphocyte infusion for leukaemia relapse after allogeneic stem cell transplantation.
    Lam MF; Au WY; Tse KC; Chan TM; Chan GS; Chan KW; Lai KN
    Am J Hematol; 2007 Apr; 82(4):327-8. PubMed ID: 17177190
    [No Abstract]   [Full Text] [Related]  

  • 19. A pilot study of prophylactic donor lymphocyte infusions to prevent relapse in adult acute lymphoblastic leukemias after allogeneic hematopoietic stem cell transplantation.
    Lutz C; Massenkeil G; Nagy M; Neuburger S; Tamm I; Rosen O; Dörken B; Arnold R
    Bone Marrow Transplant; 2008 May; 41(9):805-12. PubMed ID: 18195682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Need for an accurate molecular diagnosis to assess the donor origin of leukemia relapse after allogeneic stem cell transplantation.
    Spinelli O; Giussani U; Borleri G; Lazzari M; Michelato A; Dotti G; Barbui T; Rambaldi A
    Haematologica; 2000 Nov; 85(11):1153-7. PubMed ID: 11064467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.